Early experience demonstrates that spRDG is feasible, safe, and oncologically adequate in appropriately selected patients. Successful implementation requires familiarity with platform-specific ergonomics and workflow. Until supported by larger studies, indications should remain focused on distal gastrectomy requiring D1 + LND.
Lim et al. (Thu,) studied this question.